| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/06/1995 | WO1995009183A1 Peptide and antithrombotic agent |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009181A1 Peptide containing amino acid sequence of fimbrial protein of porphyromonas gingivalis and use thereof |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995008999A1 AMELIORATION OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY DEPOSITION OF AMYLOID β PROTEIN |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | WO1995003417A3 Homologously recombinant slow growing mycobacteria and uses therefor |
| 04/06/1995 | EP0667871A4 Biologically active amphiphilic peptide compositions and uses therefor. |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/06/1995 | CA2172961A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172547A1 Expression of human d4 dopamine receptors in stable cell lines |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | CA2149627A1 Amelioration of amnesia in alzheimer's disease caused by deposition of amyloid .beta. protein |
| 04/05/1995 | EP0646794A1 Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it |
| 04/05/1995 | EP0646792A1 Use of amylin in pharmaceutical screens |
| 04/05/1995 | EP0646646A2 Protein expression system |
| 04/05/1995 | EP0646645A2 A process for producing a substance |
| 04/05/1995 | EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions |
| 04/05/1995 | EP0646643A1 Modified human granulocyte macrophage-colony stimulating factor gene and expression thereof in yeast |
| 04/05/1995 | EP0646601A1 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
| 04/05/1995 | EP0646599A2 Modification of pertussis toxin |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646594A1 Protein purification method |
| 04/05/1995 | EP0646379A1 Insulin formulation |
| 04/05/1995 | EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
| 04/05/1995 | EP0646182A1 Process for detection of neoplastic disease. |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
| 04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
| 04/05/1995 | EP0646173A1 Reagent for agglutination assays |
| 04/05/1995 | EP0646172A1 Recombinant entomopoxvirus |
| 04/05/1995 | EP0646171A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 04/05/1995 | EP0646131A1 Serum amyloid a protein |
| 04/05/1995 | EP0646130A1 Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides. |
| 04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
| 04/05/1995 | EP0646128A1 Glucagon-like peptide and insulinotropin derivatives |
| 04/05/1995 | EP0646022A1 Prosthetic devices having enhanced osteogenic properties |
| 04/05/1995 | EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis |
| 04/05/1995 | EP0646015A1 Contraceptive vaccine |
| 04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
| 04/05/1995 | EP0646010A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
| 04/05/1995 | EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein |
| 04/05/1995 | EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 04/05/1995 | EP0469084B1 Hepatospecific insulin analogues |
| 04/05/1995 | EP0365598B1 Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 04/05/1995 | EP0318554B1 Targeted multifunctional proteins |
| 04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 04/05/1995 | EP0218625B1 Infectious bronchitis virus spike protein |
| 04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
| 04/05/1995 | CN1101208A Novel cell cortex protein |
| 04/05/1995 | CN1028107C Method to produce low-inositol hexphosphate soybean separated protein |
| 04/04/1995 | US5403926 Hepatocellular carcinoma oncogene |
| 04/04/1995 | US5403925 Detecting cancer cell progression |
| 04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
| 04/04/1995 | US5403917 Process for the quantitative selective removal or preparative isolation of tumour necrosis factor (TNF) or/and lipopolysaccharides (LPS) from aqueous liquids |
| 04/04/1995 | US5403915 Isolation and purification of lung surfactant protein |
| 04/04/1995 | US5403914 Biological mediators of immune functions |
| 04/04/1995 | US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/04/1995 | US5403825 Obtaining mammalian bone extract, treating with water to obtain aqueous extract, treating with alcohol to precipitate, treating with water and fractionating |
| 04/04/1995 | US5403745 Selective removal of interfering substances by binding with immobilized antibodies |
| 04/04/1995 | US5403737 Serine protease variants having peptide ligase activity |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 04/04/1995 | US5403730 Process for the selective deactivation of esterases and catalases in trigonopsis variabilis cells by microwave heating while retaining D-amino acid oxidase activity |
| 04/04/1995 | US5403725 Human T-cell hybridomas are incubated in medium of phorbol myristate acetate and/or concanavalin A, fractionated by sucrose density gradient centrifugation |
| 04/04/1995 | US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi |
| 04/04/1995 | US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label |
| 04/04/1995 | US5403712 Transcription cofactor assay |
| 04/04/1995 | US5403596 Anticoagulant from saliva of leech; does not inhibit thrombin |
| 04/04/1995 | US5403586 LHRH-TraTp fusion proteins |
| 04/04/1995 | US5403582 Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus |
| 04/04/1995 | US5403581 Administering immunogenic polypeptide to poultry |
| 04/04/1995 | US5403484 Viruses expressing chimeric binding proteins |
| 04/04/1995 | CA1335083C Fr901228 substance and preparation thereof |
| 04/04/1995 | CA1335077C Process for the manufacture of apolipoproteins from human blood plasma or serum |
| 04/03/1995 | EP0672152A4 Fusion proteins comprising mgf and il-3. |
| 03/31/1995 | CA2132937A1 Protein expression system |
| 03/30/1995 | WO1995008772A1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 03/30/1995 | WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
| 03/30/1995 | WO1995008632A1 Immunoreactive antigens of hepatitis e virus |
| 03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
| 03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
| 03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 03/30/1995 | WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |